Dupont Capital Management’s European Biotech Acquisition Corp. Units EBACU Stock Holding History

Dupont Capital Management’s Portfolio EBACU Stock Details EBACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4	Closed	-$42	–	1385
2022 Q4	$42	Hold	4	–	–	﹤0.01%	1352
2022 Q3	$0	Hold	4	–	–	﹤0.01%	1769
2022 Q2	$0	Hold	4	–	–	﹤0.01%	1848
2022 Q1	$0	Hold	4	–	–	﹤0.01%	1872
2021 Q4	$0	Hold	4	–	–	﹤0.01%	1928
2021 Q3	$0	Hold	4	–	–	﹤0.01%	1894
2021 Q2	$0	Sell	4 -99,996	-100%	-$1M	﹤0.01%	1934
2021 Q1	$1M	Buy	+100,000	New	+$999K	0.02%	571

Dupont Capital Management's EBACU Position: Q1 2023 in Review

Dupont Capital Management sold out of European Biotech Acquisition Corp. Units (EBACU) in Q1 2023, closing a stake of 4 shares — an estimated $42 sold.

Dupont Capital Management first reported a position in EBACU in Q1 2021 and held it in 8 quarters. The position peaked at $1M in Q1 2021. 0 funds tracked by Wall St. Rank hold EBACU as of Q1 2023.

Dupont Capital Management reported no remaining European Biotech Acquisition Corp. Units position as of Q1 2023 after selling out during the quarter.
Dupont Capital Management sold 4 European Biotech Acquisition Corp. Units shares in Q1 2023, an estimated $42.
Dupont Capital Management first reported a position in European Biotech Acquisition Corp. Units in Q1 2021 and held it in 8 quarters.
Dupont Capital Management's European Biotech Acquisition Corp. Units position peaked at $1M in Q1 2021.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Units as of Q1 2023.

Based on Dupont Capital Management's 13F filing for Q1 2023, filed 28 Apr 2023.